FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ruhe Men

Research Profile

Living Beings

Disorders

Dengue

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequences

Procedures

Anatomy

Cell Line

Co-author Network

Publications

TOP 3
Germán Añez; Ruhe Men; Kenneth H Eckels; Ching-Juh Lai
Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques.
Ching-Juh Lai; Ana P Goncalvez; Ruhe Men; Claire Wernly; Olivia Donau; ronald engle; Robert Purcell
Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
Ana P Goncalvez; Ruhe Men; Claire Wernly; Robert Purcell; Ching-Juh Lai
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ruhe Men (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Germán Añez; Ruhe Men; Kenneth H Eckels; Ching-Juh Lai
Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques.
Journal of virology 2009;83(20):10384-94.
2007: Ching-Juh Lai; Ana P Goncalvez; Ruhe Men; Claire Wernly; Olivia Donau; ronald engle; Robert Purcell
Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
Journal of virology 2007;81(23):12766-74.
2004: Ana P Goncalvez; Ruhe Men; Claire Wernly; Robert Purcell; Ching-Juh Lai
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
Journal of virology 2004;78(23):12910-8.
2004: Ruhe Men; Tetsu Yamashiro; Ana P Goncalvez; Claire Wernly; Darren Schofield; Suzanne U Emerson; Robert Purcell; Ching-Juh Lai
Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
Journal of virology 2004;78(9):4665-74.
2001: Anna P Durbin; Ruth A Karron; W Sun; D W Vaughn; M J Reynolds; John R Perreault; Bhagvanji Thumar; Ruhe Men; Ching-Juh Lai; William R Elkins; Robert M Chanock; Brian Murphy; Stephen S Whitehead
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
The American journal of tropical medicine and hygiene 2001;65(5):405-13.
2000: Ruhe Men; LS Wyatt; I Tokimatsu; S Arakaki; G Shameem; Randy Elkins; Robert M Chanock; Bernard Moss; Ching-Juh Lai
Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge.
Vaccine 2000;18(27):3113-22.
1998: Ching-Juh Lai; Mike Bray; Ruhe Men; A Cahour; W Chen; H Kawano; M Tadano; K Hiramatsu; I Tokimatsu; Alexander G Pletnev; S Arakai; G Shameem; M Rinaudo
Evaluation of molecular strategies to develop a live dengue vaccine.
Clinical and diagnostic virology 1998;10(2-3):173-9.
1998: Alexander G Pletnev; Ruhe Men
Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1746-51.
1998: Mike Bray; Ruhe Men; I Tokimatsu; Ching-Juh Lai
Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence.
Journal of virology 1998;72(2):1647-51.
1996: K Hiramatsu; M Tadano; Ruhe Men; Ching-Juh Lai
Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
Virology 1996;224(2):437-45.
1996: Mike Bray; Ruhe Men; Ching-Juh Lai
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.
Journal of virology 1996;70(6):4162-6.
1996: Ruhe Men; Mike Bray; D Clark; Robert M Chanock; Ching-Juh Lai
Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys.
Journal of virology 1996;70(6):3930-7.
1995: W Chen; H Kawano; Ruhe Men; D Clark; Ching-Juh Lai
Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice.
Journal of virology 1995;69(8):5186-90.
1995: P G Livingston; Ichiro Kurane; L C Dai; Y Okamoto; Ching-Juh Lai; Ruhe Men; S Karaki; M Takiguchi; Irene Bosch
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1287-95.
1993: Alan L Rothman; Ichiro Kurane; Ching-Juh Lai; Mike Bray; B Falgout; Ruhe Men; Irene Bosch
Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes.
Journal of virology 1993;67(2):801-6.
1991: Ruhe Men; Mike Bray; Ching-Juh Lai
Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice.
Journal of virology 1991;65(3):1400-7.